EGFR/CDK2-IN-3
Product Specifications
UNSPSC Description
EGFR/CDK2-IN-3 (compound 4b) is a dual inhibitor of EGFR and CDK-2 with IC50s of 71.7 and 113.7 nM, respectively. EGFR/CDK2-IN-3 induces apoptosis in MCF-7 cells and arrests the cell cycle in the S phase. EGFR/CDK2-IN-3 has significant anti-cancer cell toxicity and inhibits MCF-7 with an IC50 of 3.16 μM[1].
Target Antigen
CDK; EGFR
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage;JAK/STAT Signaling;Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
cancer
Assay Protocol
https://www.medchemexpress.com/egfr-cdk2-in-3.html
Solubility
10 mM in DMSO
Smiles
O=C(C1=CN(C2=CC=CC=C2)N=C1C3=NN4C(SC3)=NN=C4C5=CC=CC=C5)C6=CC=C7C=CC=CC7=C6
Molecular Weight
512.58
References & Citations
[1]Salem M E, et al. Synthesis and Anti-Breast Cancer Potency of Mono-and Bis-(pyrazolyl [1, 2, 4] triazolo [3, 4-b][1, 3, 4] thiadiazine) Derivatives as EGFR/CDK-2 Target Inhibitors[J]. ACS Omega, 2023.. . .
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-156115/EGFR-CDK2-IN-3-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-156115/
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Mouse Monoclonal Ubiquilin 2 Antibody (6H9) [Alexa Fluor 350]](https://cdn.genprice.uk/genprice/genprice2.png)
NBP2-25164AF350 0.1 mL
Mouse Monoclonal Ubiquilin 2 Antibody (6H9) [Alexa Fluor 350]
Ask
View Details MBS1468084-01 0.02 mg (E-Coli)
Recombinant Staphylococcus aureus Transcriptional regulator sarA (sarA)
Ask
View Details MBS1468084-02 0.1 mg (E-Coli)
Recombinant Staphylococcus aureus Transcriptional regulator sarA (sarA)
Ask
View Details 
MBS1468084-03 0.02 mg (Yeast)
Recombinant Staphylococcus aureus Transcriptional regulator sarA (sarA)
Ask
View Details